A Randomized Clinical Trial of MK-0777 for the Treatment of Cognitive Impairments in People with Schizophrenia
Year: 2010
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Biological Psychiatry
Authors: Robert W. Buchanan, Richard S.E. Keefe, Jeffrey A. Lieberman, Deanna M. Barch, John G. Csernansky, Donald C. Goff, James M. Gold, Michael F. Green, L. Fredrik Jarskog, Daniel C. Javitt, David Kimhy, Michael S. Kraus, Joseph P. McEvoy, Raquelle I. Mesholam-Gately, Larry J. Seidman, M. Patricia Ball, Robert P. McMahon, Robert S. Kern, James Robinson, Stephen R. Marder
Institutions: University of Maryland, Baltimore, Duke Medical Center, New York State Psychiatric Institute, Columbia University, Washington University in St. Louis, Northwestern University, Harvard University, Massachusetts General Hospital, University of California, Los Angeles, VA Desert Pacific Healthcare Network, Nathan Kline Institute for Psychiatric Research, New York University, Beth Israel Deaconess Medical Center
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W2136125607